
|Articles|February 15, 2004
IntraLase sales on rise for all-laser flap device
Irvine, CA-IntraLase Corp. is seeing greater acceptance of its all-laser technology, reporting its lasers were used 136% more during the fourth quarter of 2003 than in the same quarter a year ago.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Regeneron's EYLEA HD injection 8 mg approved by FDA for the treatment of macular edema following RVO
2
Precise Bio completes procedure using PB-001, a 3D-bioprinted corneal implant
3
Defining Retinal Vascular Diseases AMD, DME, RVO
4
EyePoint receives second consecutive positive recommendation from DSMC
5


















































.png)


